Objective Measurement of Compliance During Oral Appliance Therapy for Sleep-disordered Breathing

Overview

Journal Thorax

Date 2012 Sep 21

PMID 22993169

Citations 87

Authors

Olivier M Vanderveken

Marijke Dieltjens

Kristien Wouters

Wilfried A De Backer

Paul H Van de Heyning

Marc J Braem

Affiliations

Soon will be listed here.

Abstract

Background: Oral appliance (OA) therapy is increasingly prescribed as a non-continuous positive airway pressure treatment modality for sleep-disordered breathing (SDB). Although OA therapy is reported to be efficacious for the treatment of SDB, data on compliance remain limited to self-report.

Methods: In this 3-month prospective clinical trial, the main outcome was to assess the safety and feasibility of an objective measurement of compliance during OA therapy using an embedded microsensor thermometer with on-chip integrated readout electronics in 51 consecutive patients with an established diagnosis of SDB (AHI 18.0 ± 11.9/h; age 47 ± 10 y; BMI 26.6 ± 4.0 kg/m(2); men/women: 31/20). Patients were unaware of the purpose of the study.

Results: No microsensor-related adverse events were recorded. In addition, no problems were encountered during the readout of the compliance data. Out of 51 microsensors, one had a technical defect and was lost to follow-up. In this study, the overall objective mean rate of OA use was 6.6 ± 1.3 h per day with a regular OA users' rate of 82% at the 3-month follow-up. Statistical analysis revealed no significant differences between objective and self-reported OA compliance data in this study. Measurement of the objective OA compliance allowed us to calculate the mean disease alleviation (MDA) as the product of objective compliance and therapeutic efficacy. MDA serves as a measure of the overall therapeutic effectiveness, and turned out to be 51.1%.

Conclusions: The results illustrate the safety and feasibility of objective measurement of OA compliance. The objective measurement of OA compliance allows for calculation of the MDA.

Citing Articles

Different Oral Appliance Designs Demonstrate Different Rates of Efficacy for the Treatment of Obstructive Sleep Apnea: A Review Article.

Liptak L, Sall E, Kim S, Mosca E, Charkhandeh S, Remmers J Bioengineering (Basel). 2025; 12(2).

PMID: 40001729 PMC: 11852099. DOI: 10.3390/bioengineering12020210.

Personalized Treatment for Obstructive Sleep Apnea: Beyond CPAP.

Van Daele M, Smolders Y, Van Loo D, Bultynck C, Verbraecken J, Vroegop A Life (Basel). 2024; 14(8).

PMID: 39202749 PMC: 11355307. DOI: 10.3390/life14081007.

Hypoglossal Nerve Stimulation Therapy in a Belgian Cohort of Obstructive Sleep Apnea Patients.

Van Loo D, Dieltjens M, Engelen S, Verbraecken J, Vanderveken O Life (Basel). 2024; 14(7).

PMID: 39063543 PMC: 11278378. DOI: 10.3390/life14070788.

Applications of nanotechnology in orthodontics: a comprehensive review of tooth movement, antibacterial properties, friction reduction, and corrosion resistance.

He L, Zhang W, Liu J, Pan Y, Li S, Xie Y Biomed Eng Online. 2024; 23(1):72.

PMID: 39054528 PMC: 11270802. DOI: 10.1186/s12938-024-01261-9.

Oral appliance therapy and hypoglossal nerve stimulation as non-positive airway pressure treatment alternatives for obstructive sleep apnea: a narrative expert review.

Parthasarathy S, Ayas N, Bogan R, Hwang D, Kushida C, Lown J Sleep Adv. 2024; 5(1):zpae035.

PMID: 38966620 PMC: 11223066. DOI: 10.1093/sleepadvances/zpae035.

References

Fogel R, Malhotra A, White D . Sleep. 2: pathophysiology of obstructive sleep apnoea/hypopnoea syndrome. Thorax. 2004; 59(2):159-63. PMC: 1746928. DOI: 10.1136/thorax.2003.015859. View

Ravesloot M, de Vries N . Reliable calculation of the efficacy of non-surgical and surgical treatment of obstructive sleep apnea revisited. Sleep. 2011; 34(1):105-10. PMC: 3001787. DOI: 10.1093/sleep/34.1.105. View

Piper A, Grunstein R . Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med. 2010; 183(3):292-8. DOI: 10.1164/rccm.201008-1280CI. View

Ryan C, LOVE L, Peat D, Fleetham J, Lowe A . Mandibular advancement oral appliance therapy for obstructive sleep apnoea: effect on awake calibre of the velopharynx. Thorax. 1999; 54(11):972-7. PMC: 1745384. DOI: 10.1136/thx.54.11.972. View

Gotsopoulos H, Kelly J, Cistulli P . Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep. 2004; 27(5):934-41. DOI: 10.1093/sleep/27.5.934. View

Vanderveken O, Devolder A, Marklund M, Boudewyns A, Braem M, Okkerse W . Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea. Am J Respir Crit Care Med. 2007; 178(2):197-202. DOI: 10.1164/rccm.200701-114OC. View

Grunstein R . Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea. Thorax. 1995; 50(10):1106-13. PMC: 475028. DOI: 10.1136/thx.50.10.1106. View

Dieltjens M, Vanderveken O, Van de Heyning P, Braem M . Current opinions and clinical practice in the titration of oral appliances in the treatment of sleep-disordered breathing. Sleep Med Rev. 2011; 16(2):177-85. DOI: 10.1016/j.smrv.2011.06.002. View

Krieger J, Kurtz D . Objective measurement of compliance with nasal CPAP treatment for obstructive sleep apnoea syndrome. Eur Respir J. 1988; 1(5):436-8. View

10.

Barnes M, McEvoy R, Banks S, Tarquinio N, Murray C, Vowles N . Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med. 2004; 170(6):656-64. DOI: 10.1164/rccm.200311-1571OC. View

11.

Jennum P, Kjellberg J . Health, social and economical consequences of sleep-disordered breathing: a controlled national study. Thorax. 2011; 66(7):560-6. DOI: 10.1136/thx.2010.143958. View

12.

Sullivan C, Issa F, Eves L . Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981; 1(8225):862-5. DOI: 10.1016/s0140-6736(81)92140-1. View

13.

Smith D, Stradling J . Can mandibular advancement devices be a satisfactory substitute for short term use in patients on nasal continuous positive airway pressure?. Thorax. 2002; 57(4):305-8. PMC: 1746287. DOI: 10.1136/thorax.57.4.305. View

14.

Pepin J, Bettega G, Sadek H, Raphael B, Levy P . Mandibular advancement devices: rate of contraindications in 100 consecutive obstructive sleep apnea patients. Am J Respir Crit Care Med. 2002; 166(3):274-8. DOI: 10.1164/rccm.2008167. View

15.

Almeida F . Complexity and efficacy of mandibular advancement splints: understanding their mode of action. J Clin Sleep Med. 2011; 7(5):447-8. PMC: 3190842. DOI: 10.5664/JCSM.1302. View

16.

Brown L . Adherence-based coverage of positive airway pressure treatment for sleep apnea: the 'brave new world' of cost-saving strategies. Curr Opin Pulm Med. 2011; 17(6):403-5. DOI: 10.1097/MCP.0b013e32834bdf6e. View

17.

Weaver T, Grunstein R . Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 2008; 5(2):173-8. PMC: 2645251. DOI: 10.1513/pats.200708-119MG. View

18.

Lettieri C, Paolino N, Eliasson A, Shah A, Holley A . Comparison of adjustable and fixed oral appliances for the treatment of obstructive sleep apnea. J Clin Sleep Med. 2011; 7(5):439-45. PMC: 3190841. DOI: 10.5664/JCSM.1300. View

19.

Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S . The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993; 328(17):1230-5. DOI: 10.1056/NEJM199304293281704. View

20.

Lowe A, Sjoholm T, Ryan C, Fleetham J, Ferguson K, Remmers J . Treatment, airway and compliance effects of a titratable oral appliance. Sleep. 2000; 23 Suppl 4:S172-8. View